Email this article Economic methods of medical technology assessment in hematology
- Authors: Gurkina M.V.1, Smetanina N.S.2, Rumyntsev A.G.1
-
Affiliations:
- Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology
- Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology Department of Hematology, Oncology and radiotherapy Russian National Research Medical University named after N.I. Pirogov
- Issue: Vol 17, No 2 (2018)
- Pages: 136-143
- Section: LITERATURE REVIEW
- Submitted: 20.09.2018
- Published:
- URL: https://hemoncim.com/jour/article/view/185
- DOI: https://doi.org/10.24287/1726-1708-2018-17-2-136-143
- ID: 185
Cite item
Full Text
Abstract
The use of available resources with maximum benefit to the patient is the main goal of healthcare, therefore the economic evaluation of the effectiveness of medical technologies becomes important. In this article all modern methods of pharmacoeconomic analysis are presented in detail on the example of hematological diseases. Particular attention is paid to the characteristics by which healthcare providers can assess the validity of data on the pharmacoeconomic effectiveness of medical technologies.
About the authors
M. V. Gurkina
Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology
Author for correspondence.
Email: mvgurkina@gmail.com
ORCID iD: 0000-0003-4727-0131
adviser to General Director
Russia 117997, Moscow, Samory Mashela st., 1
Russian FederationN. S. Smetanina
Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, ImmunologyDepartment of Hematology, Oncology and radiotherapy Russian National Research Medical University named after N.I. Pirogov
ORCID iD: 0000-0003-2756-7325
Russian Federation
A. G. Rumyntsev
Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology
ORCID iD: 0000-0002-1643-5960
Russian Federation
References
Supplementary files
